Multiplex immunoassays advance personalized cancer therapy
See how to leverage multiplex immunoassays and proteomic profiling to enhance cancer diagnosis and treatment
See how to leverage multiplex immunoassays and proteomic profiling to enhance cancer diagnosis and treatment
Vote for the products that have made the most difference to your research for the chance to win a $100 Amazon Gift Card (or equivalent currency)
Learn how acoustically levitating a diamond led to a breakthrough in biotech automation
Innovation follows $1 million FARE Award
Two ELISA kits for diagnostics and two for research
New and unique opportunity to advance cancer treatment
Can the science of fats unlock a new avenue in diabetes care? UT Southwestern researchers are finding out
ELRIG appoints Dr. Del Trezise as Chair of the Board
Registration now open
The new Krios 5 Cryo-TEM enables breakthroughs in structural and cellular biology to pioneer new treatments and advance drug discovery
Dr. Chia-Lin Wei, Professor of Genome Sciences at University of Washington, shares how to unlock DNA methylation insights for neuroscience and cancer research
Explore the role of SPT Labtech's firefly system in core labs for proteomics, genomics, and multiomics applications
Interoperable AI-powered digital pathology workflows support confident cancer diagnosis
Measuring antithrombin activity levels helps people receive the appropriate dose, initially and over time
The broader diagnostic capabilities enhance Grifols leadership in developing and providing a complete set of automation solutions that optimize operations regardless of size, from small labs to large blood banks
Researchers at the University of Bern have analyzed a mechanism by which the coronavirus manipulates human cells to replicate itself
Biozen Native RP-1 and RP-5 is first of its kind in biotherapeutic antibody characterization
The new genetic analyzer supports both clinical as well as research for Sanger sequencing and fragment analysis in targeted genomic testing
In this guest editorial, Pascal Steffen-Lockhauserbäumer, Global Product Manager for timsTOF at Bruker Daltonics explores how spatial multiomics combines imaging with LC/MS to revolutionize biomolecular analysis, enabling high-resolution insights into disease mechanisms, immune response, and tissue structure, with applications in diagnostics and personalized medicine